Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Other financing activities (2023 - 2025)

Historic Other financing activities for Neurogene (NGNE) over the last 3 years, with Q3 2025 value amounting to $166000.0.

  • Neurogene's Other financing activities changed N/A to $166000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $166000.0, marking a year-over-year decrease of 9286.33%. This contributed to the annual value of $4.3 million for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, Neurogene's Other financing activities is $166000.0.
  • Over the past 5 years, Neurogene's Other financing activities peaked at $4.3 million during Q1 2024, and registered a low of -$2.0 million during Q4 2023.
  • Moreover, its 3-year median value for Other financing activities was $166000.0 (2025), whereas its average is $890600.0.